🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Ambrosia Biosciences Announces the Nonclinical Data Profiles of Two Oral Small Molecule Programs: A GLP-1 Receptor Agonist Intended for Once-Weekly Dosing and a GIP Receptor Antagonist

General Montana • November 15, 2026 •
Ambrosia Biosciences Announces the Nonclinical Data Profiles of Two Oral Small Molecule Programs: A GLP-1 Receptor Agonist Intended for Once-Weekly Dosing and a GIP Receptor Antagonist
AMB-895 and AMB-131 demonstrate highly differentiated PK profiles and robust efficacy in preclinical models
Source: Missoulian MT | https://missoulian.com/search/?f=rss&t=article&l=50&s=start_time&sd=desc - Read Original
"Free Quote Today"
"Output is a realization of Input."

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"We build AI or anything ICST"